Abstract
The t(10;11)(p13;q14) translocation leads to the fusion of the CALM and AF10 genes. This translocation can be found as the sole cytogenetic abnormality in acute lymphoblastic leukemia, acute myeloid leukemia and in malignant lymphomas. The expression of CALM/AF10 in primary murine bone marrow cells results in the development of an aggressive leukemia in a murine bone marrow transplantation model. Using a yeast two-hybrid screen, we identified the lymphoid regulator Ikaros as an AF10 interacting protein. Interestingly, Ikaros is required for normal development of lymphocytes, and aberrant expression of Ikaros has been found in leukemia. In a murine model, the expression of a dominant negative isoform of Ikaros causes leukemias and lymphomas. The Ikaros interaction domain of AF10 was mapped to the leucine zipper domain of AF10, which is required for malignant transformation both by the CALM/AF10 and the MLL/AF10 fusion proteins. The interaction between AF10 and Ikaros was confirmed by GST pull down and co-immunoprecipitation. Coexpression of CALM/AF10 but not of AF10 alters the subcellular localization of Ikaros in murine fibroblasts. The transcriptional repressor activity of Ikaros is reduced by AF10. These results suggest that CALM/AF10 might interfere with normal Ikaros function, and thereby block lymphoid differentiation in CALM/AF10 positive leukemias.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Andrews NC, Faller DV . (1991). A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells. Nucleic Acids Res 19: 2499.
Archangelo LF, Glasner J, Krause A, Bohlander SK . (2006). The novel CALM interactor CATS influences the subcellular localization of the leukemogenic fusion protein CALM/AF10. Oncogene 25: 4099–4109.
Bohlander SK, Muschinsky V, Schrader K, Siebert R, Schlegelberger B, Harder L et al. (2000). Molecular analysis of the CALM/AF10 fusion: identical rearrangements in acute myeloid leukemia, acute lymphoblastic leukemia and malignant lymphoma patients. Leukemia 14: 93–99.
Brown KE, Guest SS, Smale ST, Hahm K, Merkenschlager M, Fisher AG . (1997). Association of transcriptionally silent genes with Ikaros complexes at centromeric heterochromatin. Cell 91: 845–854.
Caudell D, Zhang Z, Chung YJ, Aplan PD . (2007). Expression of a CALM-AF10 fusion gene leads to Hoxa cluster overexpression and acute leukemia in transgenic mice. Cancer Res 67: 8022–8031.
Chaplin T, Ayton P, Bernard OA, Saha V, Della VV, Hillion J et al. (1995). A novel class of zinc finger/leucine zipper genes identified from the molecular cloning of the t(10;11) translocation in acute leukemia. Blood 85: 1435–1441.
Cobb BS, Morales-Alcelay S, Kleiger G, Brown KE, Fisher AG, Smale ST . (2000). Targeting of Ikaros to pericentromeric heterochromatin by direct DNA binding. Genes Dev 14: 2146–2160.
Debernardi S, Bassini A, Jones LK, Chaplin T, Linder B, de Bruijn DR et al. (2002). The MLL fusion partner AF10 binds GAS41, a protein that interacts with the human SWI/SNF complex. Blood 99: 275–281.
Deshpande AJ, Cusan M, Rawat VP, Reuter H, Krause A, Pott C et al. (2006). Acute myeloid leukemia is propagated by a leukemic stem cell with lymphoid characteristics in a mouse model of CALM/AF10-positive leukemia. Cancer Cell 10: 363–374.
DiMartino JF, Ayton PM, Chen EH, Naftzger CC, Young BD, Cleary ML . (2002). The AF10 leucine zipper is required for leukemic transformation of myeloid progenitors by MLL-AF10. Blood 99: 3780–3785.
Dreyling MH, Martinez-Climent JA, Zheng M, Mao J, Rowley JD, Bohlander SK . (1996). The t(10;11)(p13;q14) in the U937 cell line results in the fusion of the AF10 gene and CALM, encoding a new member of the AP-3 clathrin assembly protein family. Proc Natl Acad Sci USA 93: 4804–4809.
Georgopoulos K, Bigby M, Wang JH, Molnar A, Wu P, Winandy S et al. (1994). The Ikaros gene is required for the development of all lymphoid lineages. Cell 79: 143–156.
Georgopoulos K, Moore DD, Derfler B . (1992). Ikaros, an early lymphoid-specific transcription factor and a putative mediator for T cell commitment. Science 258: 808–812.
Gomez-del Arco P, Koipally J, Georgopoulos K . (2005). Ikaros SUMOylation: switching out of repression. Mol Cell Biol 25: 2688–2697.
Gomez-del Arco P, Maki K, Georgopoulos K . (2004). Phosphorylation controls Ikaros's ability to negatively regulate the G(1)-S transition. Mol Cell Biol 24: 2797–2807.
Hahm K, Ernst P, Lo K, Kim GS, Turck C, Smale ST . (1994). The lymphoid transcription factor LyF-1 is encoded by specific, alternatively spliced mRNAs derived from the Ikaros gene. Mol Cell Biol 14: 7111–7123.
Huber W, von Heydebreck A, Sultmann H, Poustka A, Vingron M . (2002). Variance stabilization applied to microarray data calibration and to the quantification of differential expression. Bioinformatics 18 (Suppl 1): S96–S104.
Kim J, Sif S, Jones B, Jackson A, Koipally J, Heller E et al. (1999). Ikaros DNA-binding proteins direct formation of chromatin remodeling complexes in lymphocytes. Immunity 10: 345–355.
Kobayashi H, Thirman MJ, Rowley JD . (1995). U937 cell line has a t(10;11)(p13–14;q14–21) rather than a deletion of 11q. Genes Chromosomes Cancer 13: 217–218.
Koipally J, Heller EJ, Seavitt JR, Georgopoulos K . (2002). Unconventional potentiation of gene expression by Ikaros. J Biol Chem 277: 13007–13015.
Linder B, Gerlach N, Jackle H . (2001). The Drosophila homolog of the human AF10 is an HP1-interacting suppressor of position effect variegation. EMBO Rep 2: 211–216.
Linder B, Newman R, Jones LK, Debernardi S, Young BD, Freemont P et al. (2000). Biochemical analyses of the AF10 protein: the extended LAP/PHD-finger mediates oligomerisation. J Mol Biol 299: 369–378.
Martin DG, Baetz K, Shi X, Walter KL, Macdonald VE, Wlodarski MJ et al. (2006). The Yng1p PHD finger is a methyl-histone binding module that recognizes lysine 4 methylated histone H3. Mol Cell Biol 26: 7871–7879.
Mellor J . (2006). It takes a PHD to read the histone code. Cell 126: 22–24.
Molnar A, Georgopoulos K . (1994). The Ikaros gene encodes a family of functionally diverse zinc finger DNA-binding proteins. Mol Cell Biol 14: 8292–8303.
Nietfeld W, Meyerhans A . (1996). Cloning and sequencing of hIk-1, a cDNA encoding a human homologue of mouse Ikaros/LyF-1. Immunol Lett 49: 139–141.
Okada Y, Feng Q, Lin Y, Jiang Q, Li Y, Coffield VM et al. (2005). hDOT1L links histone methylation to leukemogenesis. Cell 121: 167–178.
Okada Y, Jiang Q, Lemieux M, Jeannotte L, Su L, Zhang Y . (2006). Leukaemic transformation by CALM-AF10 involves upregulation of Hoxa5 by hDOT1L. Nat Cell Biol 8: 1017–1024.
Olivero S, Maroc C, Beillard E, Gabert J, Nietfeld W, Chabannon C et al. (2000). Detection of different Ikaros isoforms in human leukaemias using real-time quantitative polymerase chain reaction. Br J Haematol 110: 826–830.
Payne KJ, Huang G, Sahakian E, Zhu JY, Barteneva NS, Barsky LW et al. (2003). Ikaros isoform x is selectively expressed in myeloid differentiation. J Immunol 170: 3091–3098.
Payne KJ, Nicolas JH, Zhu JY, Barsky LW, Crooks GM . (2001). Cutting edge: predominant expression of a novel Ikaros isoform in normal human hemopoiesis. J Immunol 167: 1867–1870.
Rabbitts TH . (1994). Chromosomal translocations in human cancer. Nature 372: 143–149.
Rebollo A, Schmitt C . (2003). Ikaros, Aiolos and Helios: transcription regulators and lymphoid malignancies. Immunol Cell Biol 81: 171–175.
Ronni T, Payne KJ, Ho S, Bradley MN, Dorsam G, Dovat S . (2007). Human ikaros function in activated T cells is regulated by coordinated expression of its largest isoforms. J Biol Chem 282: 2538–2547.
Rosenbauer F, Wagner K, Kutok JL, Iwasaki H, Le Beau MM, Okuno Y et al. (2004). Acute myeloid leukemia induced by graded reduction of a lineage-specific transcription factor, PU.1. Nat Genet 36: 624–630.
Rowley JD . (1990). Recurring chromosome abnormalities in leukemia and lymphoma. Semin Hematol 27: 122–136.
Schoch C, Kohlmann A, Schnittger S, Brors B, Dugas M, Mergenthaler S et al. (2002). Acute myeloid leukemias with reciprocal rearrangements can be distinguished by specific gene expression profiles. Proc Natl Acad Sci USA 99: 10008–10013.
Sun L, Crotty ML, Sensel M, Sather H, Navara C, Nachman J et al. (1999a). Expression of dominant-negative Ikaros isoforms in T-cell acute lymphoblastic leukemia. Clin Cancer Res 5: 2112–2120.
Sun L, Goodman PA, Wood CM, Crotty ML, Sensel M, Sather H et al. (1999b). Expression of aberrantly spliced oncogenic ikaros isoforms in childhood acute lymphoblastic leukemia. J Clin Oncol 17: 3753–3766.
Sun L, Heerema N, Crotty L, Wu X, Navara C, Vassilev A et al. (1999c). Expression of dominant-negative and mutant isoforms of the antileukemic transcription factor Ikaros in infant acute lymphoblastic leukemia. Proc Natl Acad Sci USA 96: 680–685.
Sun L, Liu A, Georgopoulos K . (1996). Zinc finger-mediated protein interactions modulate Ikaros activity, a molecular control of lymphocyte development. EMBO J 15: 5358–5369.
Tebar F, Bohlander SK, Sorkin A . (1999). Clathrin assembly lymphoid myeloid leukemia (CALM) protein: localization in endocytic-coated pits, interactions with clathrin, and the impact of overexpression on clathrin-mediated traffic. Mol Biol Cell 10: 2687–2702.
Trinh LA, Ferrini R, Cobb BS, Weinmann AS, Hahm K, Ernst P et al. (2001). Down-regulation of TDT transcription in CD4(+)CD8(+) thymocytes by Ikaros proteins in direct competition with an Ets activator. Genes Dev 15: 1817–1832.
Westman BJ, Mackay JP, Gell D . (2002). Ikaros: a key regulator of haematopoiesis. Int J Biochem Cell Biol 34: 1304–1307.
Winandy S, Wu P, Georgopoulos K . (1995). A dominant mutation in the Ikaros gene leads to rapid development of leukemia and lymphoma. Cell 83: 289–299.
Wysocka J, Swigut T, Xiao H, Milne TA, Kwon SY, Landry J et al. (2006). A PHD finger of NURF couples histone H3 lysine 4 trimethylation with chromatin remodelling. Nature 442: 86–90.
Yoshida T, Ng SY, Zuniga-Pflucker JC, Georgopoulos K . (2006). Early hematopoietic lineage restrictions directed by Ikaros. Nat Immunol 7: 382–391.
Acknowledgements
We thank Pablo Gomez, Katia Georgopoulos and Steven Smale for sending us Ikaros materials. Yihui Lin and Guoliang Xu generously provided AF10 constructs. Brigitte Mack and Manuel Deutsch kindly shared their expertise with the confocal microscope. This project was supported by the German José-Carreras-Leukemia Foundation with a scholarship (F05/06) to Philipp Greif and by a NGFN (Bundesministerium für Bildung und Forschung) grant to SK Bohlander.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Greif, P., Tizazu, B., Krause, A. et al. The leukemogenic CALM/AF10 fusion protein alters the subcellular localization of the lymphoid regulator Ikaros. Oncogene 27, 2886–2896 (2008). https://doi.org/10.1038/sj.onc.1210945
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1210945
Keywords
This article is cited by
-
The target cell of transformation is distinct from the leukemia stem cell in murine CALM/AF10 leukemia models
Leukemia (2016)
-
The upstreams and downstreams of H3K79 methylation by DOT1L
Chromosoma (2016)
-
Identification and characterization of OSTL (RNF217) encoding a RING-IBR-RING protein adjacent to a translocation breakpoint involving ETV6 in childhood ALL
Scientific Reports (2014)
-
CALM/AF10-positive leukemias show upregulation of genes involved in chromatin assembly and DNA repair processes and of genes adjacent to the breakpoint at 10p12
Leukemia (2012)
-
FHL2 interacts with CALM and is highly expressed in acute erythroid leukemia
Blood Cancer Journal (2011)